{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:22:52Z","timestamp":1788650572440,"version":"build-2803163510"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1097\/md.0000000000006639","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T13:11:39Z","timestamp":1492607499000},"page":"e6639","source":"Crossref","is-referenced-by-count":7,"title":["Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2\/IFN-\u03b3 expression of T cells in vitro?"],"prefix":"10.1097","volume":"96","author":[{"given":"Naibao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-45-20210226","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5055\/jom.2008.0027","article-title":"Opioid rotation in patients with cancer: a review of the current literature","volume":"4","author":"Vadalouca","year":"2008","journal-title":"J Opioid Manag"},{"key":"R2-45-20210226","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-3476(95)70370-5","article-title":"Control of severe pain in children with terminal malignancy","volume":"126","author":"Collins","year":"1995","journal-title":"J Pediatr"},{"key":"R3-45-20210226","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.292.17.2141","article-title":"Caring for the child with cancer at the close of life: \u201cThere are people who make it, and I\u2019m hoping I\u2019m one of them\u201d","volume":"292","author":"Hurwitz","year":"2004","journal-title":"JAMA"},{"key":"R4-45-20210226","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1542\/peds.2005-1479","article-title":"Symptoms affecting children with malignancies during the last month of life: A nationwide follow-up","volume":"117","author":"Jalmsell","year":"2006","journal-title":"Pediatrics"},{"key":"R5-45-20210226","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM200002033420506","article-title":"Symptoms and suffering at the end of life in children with cancer","volume":"342","author":"Wolfe","year":"2000","journal-title":"N Engl J Med"},{"key":"R6-45-20210226","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.44.5.857","article-title":"Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies","volume":"44","author":"Cherny","year":"1994","journal-title":"Neurology"},{"key":"R7-45-20210226","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0885-3924(97)00009-2","article-title":"Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies","volume":"14","author":"Martin","year":"1997","journal-title":"Pain Symptom Manage"},{"key":"R8-45-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(98)00138-9","article-title":"Assessment and treatment of neuropathic cancer pain following WHO guidelines","volume":"79","author":"Grond","year":"1999","journal-title":"Pain"},{"key":"R9-45-20210226","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1345\/aph.1A256","article-title":"Adjuvant ketamine analgesia for the management of cancer pain","volume":"36","author":"McQueen","year":"2002","journal-title":"Ann Pharmacother"},{"key":"R10-45-20210226","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jpain.2007.02.429","article-title":"Ketamine as an adjuvant for treatment of cancer pain in children and adolescents","volume":"8","author":"Finkel","year":"2007","journal-title":"J Pain"},{"key":"R11-45-20210226","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0885-3924(95)00102-5","article-title":"Longterm ketamine subcutaneous continuous infusion in neuropathic cancer pain","volume":"10","author":"Mercadante","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"R12-45-20210226","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1526-4637.2010.00863.x","article-title":"Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: A case report","volume":"11","author":"Elsewaisy","year":"2010","journal-title":"Pain Med"},{"key":"R13-45-20210226","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00045391-200607000-00004","article-title":"Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain","volume":"13","author":"Webster","year":"2006","journal-title":"Am J Ther"},{"key":"R14-45-20210226","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.biopha.2006.06.021","article-title":"The role of ketamine in pain management","volume":"60","author":"Visser","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"R15-45-20210226","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1213\/01.ANE.0000118109.12855.07","article-title":"Ketamine as adjuvant analgesic to opioids: A quantitative and qualitative systematic review","volume":"99","author":"Subramaniam","year":"2004","journal-title":"Anesth Analg"},{"key":"R16-45-20210226","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/00003246-199809000-00022","article-title":"Ketamine significantly reduces the migration of leukocytes through endothelial cell monolayers","volume":"26","author":"Hofbauer","year":"1998","journal-title":"Crit Care Med"},{"key":"R17-45-20210226","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1213\/01.ANE.0000082995.44040.07","article-title":"Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental and halothane, but not by propofol: Mediating mechanisms and prophylactic measures","volume":"97","author":"Melamed","year":"2003","journal-title":"Anesth Analg"},{"key":"R18-45-20210226","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.4049\/jimmunol.162.7.3819","article-title":"Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-zeta-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice","volume":"162","author":"Zhang","year":"1999","journal-title":"J Immunol"},{"key":"R19-45-20210226","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00045391-200607000-00004","article-title":"Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain","volume":"13","author":"Webster","year":"2006","journal-title":"Am J Ther"},{"key":"R20-45-20210226","doi-asserted-by":"crossref","first-page":"493","DOI":"10.36076\/ppj.2007\/10\/493","article-title":"Ketamine: An introduction for the pain and palliative medicine physician","volume":"10","author":"Okon","year":"2007","journal-title":"Pain Physician"},{"key":"R21-45-20210226","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/1053-0770(93)90207-2","article-title":"Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine","volume":"7","author":"Hartvig","year":"1993","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R22-45-20210226","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1460-9592.2001.00705.x","article-title":"Ketamine for short ambulatory procedures in children: An audit","volume":"11","author":"Gloor","year":"2001","journal-title":"Paediatr Anaesth"},{"key":"R23-45-20210226","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1460-9592.2006.02145.x","article-title":"Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department","volume":"17","author":"Herd","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"R24-45-20210226","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1542\/peds.109.2.236","article-title":"Risk reduction in pediatric procedural sedation by application of an American Academy of Pediatrics\/American Society of Anesthesiologists process model","volume":"109","author":"Hoffman","year":"2002","journal-title":"Pediatrics"},{"key":"R25-45-20210226","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1553-2712.2010.00922.x","article-title":"Current practice and tolerance for risk in performing procedural sedation and analgesia on children who have not met fasting guidelines: A canadian survey using a stated preference discrete choice experiment","volume":"17","author":"Bhatt","year":"2010","journal-title":"Acad Emerg Med"},{"key":"R26-45-20210226","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00043426-200112000-00013","article-title":"Longterm treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor","volume":"23","author":"Klepstad","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"R27-45-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpainsymman.2005.05.007","article-title":"Ketamine use for reduction of opioid tolerance in a 5-year-old girl with end-stage abdominal neuroblastoma","volume":"30","author":"Anghelescu","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R28-45-20210226","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/01.mph.0000140656.96085.2c","article-title":"Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma","volume":"26","author":"Tsui","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R29-45-20210226","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0885-3924(98)00144-4","article-title":"Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain","volume":"17","author":"Fine","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"R30-45-20210226","first-page":"720","article-title":"Epidural morphine for 15 patients with refractory cancer pain","volume":"09","author":"Wang","year":"2006","journal-title":"Chinese J Cancer Prev Treat"},{"key":"R31-45-20210226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1824728","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK2801","volume":"251","author":"Trujillo","year":"1991","journal-title":"Science"},{"key":"R32-45-20210226","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(94)91538-5","article-title":"Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists","volume":"633","author":"Trujillo","year":"1994","journal-title":"Brain Res"},{"key":"R33-45-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199855010-00001","article-title":"Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes","volume":"55","author":"Wiesenfeld-Hallin","year":"1998","journal-title":"Drugs"},{"key":"R34-45-20210226","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1213\/ane.0b013e3181733ddd","article-title":"Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient","volume":"107","author":"Grande","year":"2008","journal-title":"Anesth Analg"},{"key":"R35-45-20210226","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00000542-199612000-00017","article-title":"Ketamine attenuates and reverses morphine tolerance in rodents","volume":"85","author":"Shimoyama","year":"1996","journal-title":"Anesthesiology"},{"key":"R36-45-20210226","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3959(94)00139-6","article-title":"Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization","volume":"60","author":"Persson","year":"1995","journal-title":"Pain"},{"key":"R37-45-20210226","first-page":"250","article-title":"Splenic natural killer cell activity is suppressed by ligation of unilateral mental nerve in rats","volume":"49","author":"Sunagawa","year":"2000","journal-title":"Masui"},{"key":"R38-45-20210226","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/brbi.1994.1023","article-title":"Intermittent but not continuous inescapable foot shock stress affects immune responses and immunocyte beta-endorphin concent rations the rat","volume":"8","author":"Sacerdote","year":"1994","journal-title":"Brain Behav Immun"},{"key":"R39-45-20210226","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(98)00843-9","article-title":"Brain vasopressin is involved in stressinduced suppression of immune function in the rat","volume":"808","author":"Shibasaki","year":"1998","journal-title":"Brain Res"},{"key":"R40-45-20210226","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.2749256","article-title":"The periaqueductal gray matter mediates opiate induced immunosuppression","volume":"245","author":"Weber","year":"1989","journal-title":"Science"},{"key":"R41-45-20210226","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1073\/pnas.95.11.6326","article-title":"Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene","volume":"95","author":"Gaveriaux-Ruff","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R42-45-20210226","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-5728(98)00265-3","article-title":"Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model","volume":"95","author":"Roy","year":"1999","journal-title":"J Neuroimmunol"},{"key":"R43-45-20210226","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1749-6632.2000.tb05440.x","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in normal and skin-grafted mice","volume":"917","author":"Sacerdote","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"R44-45-20210226","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0192-0561(93)90057-6","article-title":"Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures","volume":"15","author":"Chao","year":"1993","journal-title":"Int J Immunopharmacol"},{"key":"R45-45-20210226","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1006\/bbrc.1998.8415","article-title":"Morphine modulates NF kappa B activation in macrophages","volume":"245","author":"Roy","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-45-20210226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(01)00248-X","article-title":"Expression of functional mu-opioid receptors during T cell development","volume":"114","author":"McCarthy","year":"2001","journal-title":"J Neuroimmunol"},{"key":"R47-45-20210226","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/S0024-3205(02)02087-8","article-title":"Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486)","volume":"71","author":"Liang-Suo","year":"2002","journal-title":"Life Sci"},{"key":"R48-45-20210226","first-page":"47","article-title":"Effect of morphine on phagocytic activity of the polymorphonuclears and monocytes","volume":"134","author":"Luza","year":"1992","journal-title":"Acta Univ Palacki Olomuc Fac Med"},{"key":"R49-45-20210226","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0022-3565(25)10382-0","article-title":"Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis","volume":"263","author":"Liu","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"R50-45-20210226","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/0-306-47611-8_11","article-title":"Effects of morphine on T-cell recirculation in rhesus monkeys","volume":"493","author":"Donahoe","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"R51-45-20210226","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3565(25)24111-8","article-title":"Morphine pellet-induced immunomodulation in mice: temporal relationships","volume":"245","author":"Bryant","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R52-45-20210226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/0-306-47611-8_15","article-title":"Opiates promote T cell apoptosis through JNK and caspase pathway","volume":"493","author":"Singhal","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"R53-45-20210226","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1189\/jlb.1203639","article-title":"Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation","volume":"75","author":"Bhat","year":"2004","journal-title":"J Leukoc Biol"},{"key":"R54-45-20210226","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1213\/01.ANE.0000082995.44040.07","article-title":"Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: Mediating mechanisms and prophylactic measures","volume":"97","author":"Melamed","year":"2003","journal-title":"Anesth Analg"},{"key":"R55-45-20210226","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1213\/00000539-199909000-00024","article-title":"Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro","volume":"89","author":"Kawasaki","year":"1999","journal-title":"Anesth Analg"},{"key":"R56-45-20210226","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF03016701","article-title":"Ketamine is omer ssuppress superantigen induced proinflammatory cytokine production in human whole blood","volume":"48","author":"Kawasaki","year":"2001","journal-title":"Can J Anaesth"},{"key":"R57-45-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/bja\/aeq169","article-title":"Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells","volume":"105","author":"Braun","year":"2010","journal-title":"Br J Anaesth"},{"key":"R58-45-20210226","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1213\/ane.0b013e3181adc384","article-title":"Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response","volume":"109","author":"Ohta","year":"2009","journal-title":"Anesth Analg"},{"key":"R59-45-20210226","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1254\/jphs.11113FP","article-title":"In vitro and in vivo effects of ketamine on generation and function of dendritic cells","volume":"117","author":"Zeng","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"R60-45-20210226","first-page":"1741","article-title":"Effect of ketamine on the differenation of human T helper cells on vitro","volume":"31","author":"Gao","year":"2011","journal-title":"Acta Univ Med Nanjing"},{"key":"R61-45-20210226","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jss.2016.02.031","article-title":"Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4(+)CD25(+)Foxp3(+) regulatory T cells in vitro","volume":"203","author":"Hou","year":"2016","journal-title":"J Surg Res"},{"key":"R62-45-20210226","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/bja\/aem218","article-title":"Low-dose ketamine affects immune responses in humans during the early postoperative period","volume":"99","author":"Beilin","year":"2007","journal-title":"Br J Anaesth"},{"key":"R63-45-20210226","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-3623(94)00162-G","article-title":"Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone","volume":"26","author":"Thomas","year":"1995","journal-title":"Gen Pharmacol"},{"key":"R64-45-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.1997.1147","article-title":"Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes","volume":"179","author":"Roy","year":"1997","journal-title":"Cell Immunol"},{"key":"R65-45-20210226","doi-asserted-by":"crossref","first-page":"37622","DOI":"10.1074\/jbc.M301224200","article-title":"Morphine negatively regulates interferon-\u03b3 promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"R66-45-20210226","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1074\/jbc.M604367200","article-title":"Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"R67-45-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0163-7258(90)90012-Q","article-title":"Interferon-gamma: producer cells, activation stimuli, and molecular genetic regulation","volume":"45","author":"Young","year":"1990","journal-title":"Pharmacol Ther"},{"key":"R68-45-20210226","doi-asserted-by":"crossref","first-page":"37622","DOI":"10.1074\/jbc.M301224200","article-title":"Morphine negatively regulates Interferon-\u03b3 promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:07:54Z","timestamp":1750201674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201704210-00045"}},"subtitle":["A prospective, randomized, double-blind study"],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":68,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006639","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}